Search results
Results from the WOW.Com Content Network
Pages in category "Experimental cancer drugs" The following 200 pages are in this category, out of approximately 262 total. This list may not reflect recent changes .
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.
Experimental cancer drugs (262 P) D. Drugs with undisclosed chemical structures (42 P) E. Experimental anti-obesity drugs (5 C, 20 P) Experimental antiviral drugs (45 P)
Peregrine Pharmaceuticals , a developmental stage biotech focusing on oncology treatments, recently announced that its lead drug candidate, bavituximab, was heading to phase 3 trials. This is a ...
I can somewhat speak from the heart on this, as I lost my mother to non-small-cell lung cancer three years ago and. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Sintilimab (IBI308), a human anti-PD-1 antibody developed by Innovent and Eli Lilly for patients with non-small cell lung cancer . [ 27 ] Tislelizumab (BGB-A317) is a humanized IgG4 anti–PD-1 monoclonal antibody in pivotal Phase 3 and Phase 2 clinical trials in solid tumors and hematologic cancers .
The company said it will no longer focus on developing the drug, poziotinib, for treating non-small cell lung cancer (NSCLC) with a rare genetic mutation that affects 2%-4% of the cancer patients.